newsletter masthead
July 19, 2019
Dr. Stan Gerson Stan Gerson, MD
Director, Case Comprehensive Cancer Center
Can't Miss Case CCC TED Talks on July 25
Next week, we will come together as a center at our Annual Scientific Retreat. Members, fellows, post-docs and trainees have the opportunity to enjoy each other's company, hear updates from leadership, discuss research findings across the spectrum from colleagues and participate in program-specific breakout sessions.
This year, we have opened a portion of our retreat to the community with engaging TED-style talks from three prominent researcher leaders from each of our affiliated institutions. These talks will take place beginning at 5pm on Thursday in the ballroom at Tinkham Veale University Center. These three leaders in their fields provide remarkable insight and passion for breaking ground in new areas, leading by collaboration and always seeking to better mankind.  While I know you will enjoy each of these talks, I hope you will invite others to take the opportunity to hear from them as well. View topics and read about each of Thursday's presenters>

Thursday's program is open to all and the full retreat agenda is available for those members, fellows, post-docs and trainees registered for the two-day event. We look forward to seeing you there!
Schiemann to Lead Athymic Animal and Preclinical Therapeutics Shared Resource
We are pleased to announce that  William Schiemann, PhD  has accepted the role of Director of the Case William Schiemann Comprehensive Cancer Center's Athymic Animal and Preclinical Therapeutics Shared Resource. Schiemann joins co-Director Daniel Lindner, MD, PhD in leading the two-location facility at Case Western Reserve University and Cleveland Clinic Taussig Cancer Institute.

Schiemann is the Goodman-Blum Professor in Cancer Research and member of the Case CCC's Molecular Oncology Program. The goal of the Athymic Animal and Preclinical Therapeutic Shared Resource is to  help in evaluation of new pharmacologic agents by providing data on tumor growth, metastasis, angiogenesis and gene expression.
Team Case CCC is Ready to Roll for VeloSano 6: Cheer, Volunteer, Donate or Ride!
Let Bike to Cure Weekend begin! Tonight our team will start the weekend at the VeloSano kick-off party, adorning their colorful jerseys before mounting their bikes on Saturday and riding anywhere from 10 to nearly 200 miles through Sunday! To-date, Team Case CCC has 90 members  who are committed to cancer
research, prevention, treatment and cures and have  raised $51,124 and counting. We've grown by 9 members and raised $11,316 in the past week!

Reach out to our team captains for late registration information if you're interested in riding with us. You can also get involved by volunteering for our cheer station or donating to any rider or the team as a whole to show your support!
DEPArray(TM) Technology Luncheon Seminar
July 22, 2019 | 12:30p
Discover the DEPArray NxT(TM), a revolutionary system for isolation of single cells or pure cell populations from solid tumor, liquid biopsy and FFPE specimens, even for samples with low cellularity. By resolving sample heterogeneity, it enables the full power of NGS analysis for any sample type, eliminating background noise. View the event invitation>

On Monday, July 22, 2019, Raimo Tanzi, PhD, Chief Market Development Officer of Menarini Silicon Biosystems will visit Case Western Reserve University and present on how DEPArray(TM) Technology Enables Automated, Precise, and Pure Target-Cell Recovery at 1pm in the Wolstein Research Building conference room 3-136. Lunch will begin at 12:30pm. RSVP today>
Case Comprehensive Cancer Center Annual Scientific Retreat
Next week, our entire center will come together - one of the few times a year we have the opportunity to do so - to collaborate and enjoy each other's company at the center's Annual Scientific Retreat July 25 and 26.

The retreat agenda is now available with TED-style talks from prominent Cleveland research leaders, a reception, keynote, scientific presentations and breakout sessions for programs that you won't want to miss! Friday's program features a keynote presentation from Anil Rustgi, MD, Director of the Herbert Irving Comprehensive Cancer Center and leading cancer researcher of gastrointestinal tumors.   Register for retreat today>
Registration Now Open: Artificial Intelligence in Oncology Symposium
Oct 24, 2019 | Tinkham Veale University Center

On October 24, the Case Comprehensive Cancer Center will host the inaugural Artificial Intelligence in Oncology Symposium: Advancements in Policy at Case Western Reserve University.

The symposium will bring together experts in AI and machine learning  as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology to speak on research developments, regulatory policy, reimbursement and ethics surrounding AI.

Symposium Highlights:
  • Focused panel discussions
  • Networking opportunities
  • Exhibitions available throughout the day
Be sure to register by August 30, 2019 to secure our discounted early bird registration. A discounts for students and trainees who wish to attend is available. We look forward to seeing you in October!  Save your seat>
Innovators in AYA Cancer: Driving Science and Policy toward a Brighter Future for Teens and Young Adults with Cancer
Nov 14-15, 2019 | Tinkham Veale University Center
Registration will be opening soon for the Case Comprehensive Cancer Center's AYA Oncology Symposium taking place November 14-15, 2019 at Tinkham Veale University Center at Case Western Reserve University! Sign up to receive updates>
National Institutes of Health Lasker Clinical Research Scholars Program
Deadline: Aug 30, 2019

The National Institutes of Health, in partnership with
the Lasker Foundation, is pleased to announce the Lasker Clinical Research Scholars Program, an historic "intramural-extramural" partnership to nurture the next generation of clinical researchers. The program supports a small number of exceptional clinical researchers in the early stages of their careers to promote their development to fully independent positions. Successful candidates are designated as Lasker Clinical Research Scholars.

Lasker Scholars receive a unique combination of NIH funding for clinical research for up to 10 years. In the first phase of the program, Scholars will receive appointments for 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent budgets. In the second phase, successful Scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or the Scholar can be considered to remain as an investigator within the intramural program.

L asker Scholars will have access to the NIH Clinical Center, the nation's largest hospital devoted entirely to clinical research. Through an arrangement with the Lasker Foundation, Scholars will have the opportunity to participate in selected activities, including attendance at the Lasker Breakfast and Award Luncheon, and participation in annual scientific meetings.  Learn more>
Conquer Cancer Now Award
LOI Deadline: Sept 5, 2019

The Conquer Cancer Now Award is a $60,000 grant given to young and innovative cancer researchers focused on   cancer genetics, cancer biology and cancer immunology. Approximately 20 researchers receive a $60,000 Conquer Cancer Now Award per year for the two-year grant cycle. 

Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies. Grant guidelines and application information>
When Patients Need Opioids to Ease the Pain
New York Times - July 10, 2019
" Some patients genuinely need powerful painkillers to make their excruciating existence at least somewhat tolerable," says Mikkael Sekeres, MD, director of the leukemia program at Cleveland Clinic and member, Case CCC.

Microsoft Quantum Algorithm Boosts Medical Imaging
Fortune - July 15, 2019
A project led by professor of radiology and Case CCC member, Mark Griswold, PhD where  researchers found they could produce scans in one third to one sixth of the time it took previously, while simultaneously boosting scan precision by more than 25% is featured in this article.

Cleveland Clinic Catalyst eNews- July 19, 2019
Case CCC 's Deputy Director for Cleveland Clinic,
Brian Bolwell, MD explains  how funding from VeloSano impacts cancer research.
NIH BULLETIN - Notices and Funding Opportunities
Pre-Application Webinar for RFA-CA-19-055 "Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trials Not Allowed)"

Correction to RFA-CA-19-034 "Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities"

Notice of Change to the Award Budget for PAR-18-303 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Accelerate Dissemination of Emerging Glycoscience Tools through Collaborations Between Developers and Early Adopters

Requests for Proposal
Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)

Extramural Loan Repayment Program for Pediatric Research (LRP-PR)

Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)

Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)

Fri, July 19
VeloSano Bike To Cure Weekend
Mon, July 22
DEPArray(TM) Technology Luncheon Seminar
12:30p WRB 3-136
Tues, July 23
Cancer Impact Lecture
Xiaorong Gu, PhD
1p NE1-205
Thurs, July 25
Developmental Therapeutics Journal Club
9a NE6-218

Molecular Biology and Microbiology Virology Journal Club
1p SOM W203

Case CCC Annual Scientific Retreat
2:30p Tinkham Veale University Center

Case CCC TED Talks at the Annual Scientific Retreat
Brian Bolwell, MD
Peter Pronovost, MD, PhD, FCCM
Mark Griswold, PhD
5p Tinkham Veale University Center
Fri, July 26
Case CCC Annual Scientific Retreat
7:45a Corporate College East
Thurs, Aug 1
Developmental Therapeutics Journal Club
9a NE6-218

Molecular Biology and Microbiology Virology Journal Club
1p SOM W203

Deadline: Open

Deadline: Open

Deadline: Open
Case Comprehensive Cancer Center